Comparing Outcomes of Upper Extremity Brachiobasilic Arteriovenous Fistulas and Arteriovenous Grafts: A Systematic Review and Meta-Analysis

Abstract

Objective:

It is unclear what the optimal upper extremity hemodialysis access is for patients without a suitable cephalic vein for arteriovenous fistulas (AVFs). The objective of this systematic review and meta-analysis was to compare the outcomes for upper extremity transposed brachiobasilic AVFs (BBAVFs) and prosthetic arteriovenous grafts (AVGs).

Methods:

A systematic review was performed to identify all English publications and abstracts comparing the patency outcomes of upper extremity BBAVFs and AVGs (January 1st, 1994 to April 1st, 2020). The outcomes assessed were 1-year and 2-year primary and secondary patency rates. Pooled odds ratios (OR) were calculated using the random-effects model, and I² statistic was used to assess between-study variability.

Results:

Twenty-three studies examining 2799 patients were identified and included in the study. The 1-year primary patency rates (OR = 1.68, 95% CI 1.24–2.28, p = 0.001, I² = 69.40%) and 2-year primary patency rates (OR = 2.33, 95% CI 1.59–3.43, p < 0.001, I² = 68.26%) were significantly better for BBAVFs than AVGs. Compared to AVGs, the 1-year secondary patency rates (OR = 1.45, 95% CI 1.05–1.98, p = 0.022, I² = 56.64%) and 2-year secondary patency rates (OR = 1.93, 95% CI 1.39–2.68, p < 0.001, I² = 57.61%) were also significantly higher for BBAVFs.

Conclusion:

The outcomes for upper extremity BBAVFs appear to be consistently superior to prosthetic hemodialysis access. This analysis supports the preferential placement of BBAVFs over AVGs in patients with a suitable upper extremity basilic vein.

Keywords

AV fistula dialysis access dialysis prosthetic grafts meta-analysis systematic review transposed brachiobasilic fistulas

Get full access to this article

View all access options for this article.

References

United States Renal Data System. 2018 USRDS annual data report: epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2018.

Schieppati

Remuzzi

Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int Suppl 2005; 98: S7–S10.

Fila

Roca-Tey

Malik

, et al. Quality assessment of vascular access procedures for hemodialysis: a position paper of the Vascular Access Society based on the analysis of existing guidelines. J Vasc Access 2020; 21: 148–153.

Nordyke

Reichert

Bylsma

, et al. Costs attributable to arteriovenous fistula and arteriovenous graft placements in hemodialysis patients with medicare coverage. Am J Nephrol 2019; 50: 320–328.

Lok

CE.

Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol 2007; 2: 1043–1053.

Lok

Huber

Lee

, et al. KDOQI Clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis 2020; 75: S1–S164.

Dagher

Gelber

Ramos

, et al. The use of basilic vein and brachial artery as an AV fistula for long term hemodialysis. J Surg Res 1976; 20: 373–376.

Coburn

Carney

Jr.

Comparison of basilic vein and polytetrafluoroethylene for brachial arteriovenous fistula. J Vasc Surg 1994; 20: 896–902; discussion 903–904.

Lee

Liu

, et al. Brachiobasilic fistula as a secondary access procedure: an alternative to a dialysis prosthetic graft. Chang Gung Med J 2004; 27: 816–23.

10.

Marques

Sadaghianloo

Fouilhe

, et al. Higher patency of transposed brachio-basilic arteriovenous fistulas compared to brachio-axillary grafts for hemodialysis patients. J Vasc Access 2015; 16: 486–492.

11.

Lazarides

Georgiadis

Papasideris

, et al. Transposed brachial-basilic arteriovenous fistulas versus prosthetic upper limb grafts: a meta-analysis. Eur J Vasc Endovasc Surg 2008; 36: 597–601.

12.

Cumpston

Page

, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev 2019; 10: ED000142.

13.

Liberati

Altman

Tetzlaff

, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62(10): e1–e34.

14.

EndNote 2018. Version X9. Clarivate analytics.

15.

Comprehensive Meta-Analysis Version 3. Borenstein, M., Hedges, L., Higgins, J., & Rothstein, H. Englewood, NJ: Biostat, 2013.

16.

Peterson

Welch

Losos

, et al. The Newcastle-Ottawa scale (NOS) for Assessing The Quality of Nonrandomised Studies in Meta-Analyses. Ottawa: Ottawa Hospital Research Institute.

17.

Jadad

Moore

Carroll

, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1–12.

18.

Mohan

Adler

DG.

Heterogeneity in systematic review and meta-analysis: how to read between the numbers. Gastrointest Endosc 2019; 89: 902–903.

19.

Keuter

De Smet

Kessels

, et al. A randomized multicenter study of the outcome of brachial-basilic arteriovenous fistula and prosthetic brachial-antecubital forearm loop as vascular access for hemodialysis. J Vasc Surg 2008; 47: 395–401.

20.

Davoudi

Tayebi

Beheshtian

Primary patency time of basilic vein transposition versus prosthetic brachioaxillary access grafts in hemodialysis patients. J Vasc Access 2013; 14: 111–115.

21.

Tayebi

Kazemzadeh

Modaghegh

MHS

, et al. Brachio-basilic upper arm transposition fistulas vs. prosthetic brachio-axillary vascular access grafts-Which one is preferred for hemodialysis? Hemodial Int 2020; 24:182–187.

22.

Chemla

Morsy

MA.

Is basilic vein transposition a real alternative to an arteriovenous bypass graft? A prospective study. Semin Dial 2008; 21: 352–356.

23.

Milburn

Szucs

, et al. Transposed brachiobasilic fistula or PTFE arm graft - alternative or complementary? J Vasc Access 2008; 9: 117–121.

24.

Kakkos

Andrzejewski

Haddad

, et al. Equivalent secondary patency rates of upper extremity Vectra Vascular Access Grafts and transposed brachial-basilic fistulas with aggressive access surveillance and endovascular treatment. J Vasc Surg 2008; 47: 407–14.

25.

Matsuura

Rosenthal

Clark

, et al. Transposed basilic vein versus polytetrafluorethylene for brachial-axillary arteriovenous fistulas. Am J Surg 1998; 176: 219–221.

26.

Oliver

McCann

Indridason

, et al. Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas. Kidney Int 2001; 60: 1532–1539.

27.

Kawecka

Debska-Slizien

Prajs

, et al. Remarks on surgical strategy in creating vascular access for hemodialysis: 18 years of one center’s experience. Ann Vasc Surg 2005; 19: 590–598.

28.

Woo

Farber

Doros

, et al. Evaluation of the efficacy of the transposed upper arm arteriovenous fistula: a single institutional review of 190 basilic and cephalic vein transposition procedures. J Vasc Surg 2007; 46: 94–99; discussion 100.

29.

Weale

Bevis

Neary

, et al. A comparison between transposed brachiobasilic arteriovenous fistulas and prosthetic brachioaxillary access grafts for vascular access for hemodialysis. J Vasc Surg 2007; 46: 997–1004.

30.

Torina

Westheimer

Schanzer

HR.

Brachial vein transposition arteriovenous fistula: is it an acceptable option for chronic dialysis vascular access?

J Vasc Access 2008; 9: 39–44.

31.

Basel

Ekim

Odabasi

, et al. Basilic vein transposition fistulas versus prosthetic bridge grafts in patients with end-stage renal failure. Ann Vasc Surg 2011; 25: 634–639.

32.

Lioupis

Mistry

Rix

, et al. Comparison among transposed brachiobasilic, brachiobrachial arteriovenous fistulas and FlixeneTM vascular graft. J Vasc Access 2011; 12: 36–44.

33.

Morosetti

Cipriani

Dominijanni

, et al. Basilic vein transposition versus biosynthetic prosthesis as vascular access for hemodialysis. J Vasc Surg 2011; 54: 1713–1719.

34.

Sala Almonacil

Plaza Martinez

Zaragoza Garcia

, et al. Comparison between autogenous brachial-basilic upper arm transposition fistulas and prosthetic brachial-axillary vascular accesses for hemodialysis. J Cardiovasc Surg (Torino) 2011; 52: 725–730.

35.

Chue

Thant

Luo

, et al. Comprehensive comparison of the performance of autogenous brachial-basilic transposition arteriovenous fistula and prosthetic forearm loop arteriovenous graft in a multiethnic Asian hemodialysis population. Biomed Res Int 2016; 2016: 8693278.

36.

Akoh

JA.

Adoption of transposed basilic vein as access for hemodialysis. Saudi J Kidney Dis Transpl 2018; 29: 381–385.

37.

Drouven

de Bruin

van Roon

, et al. Outcomes of basilic vein transposition versus polytetrafluoroethylene forearm loop graft as tertiary vascular access. J Vasc Surg 2019; 69: 1180–1186.

38.

Itoga

Virgin-Downy

Mell

MW.

Forearm loop arteriovenous grafts preserve and may create new upper arm access sites. J Vasc Access 2019; 20: 691–696.

39.

Tan

Siracuse

Brooke

, et al. Comparison of one-stage and two-stage upper arm brachiobasilic arteriovenous fistula in the Vascular Quality Initiative. J Vasc Surg 2019; 69: 1187–1195.e2.

40.

Wee

IJY

Mohamed

Patel

, et al. A systematic review and meta-analysis of one-stage versus two-stage brachiobasilic arteriovenous fistula creation. J Vasc Surg 2018; 68: 285–297.

41.

Cooper

Power

DeRose

, et al. Similar failure and patency rates when comparing one- and two-stage basilic vein transposition. J Vasc Surg 2015; 61: 809–816.

42.

Bashar

Healy

Elsheikh

, et al. One-stage vs. two-stage brachio-basilic arteriovenous fistula for dialysis access: a systematic review and a meta-analysis. PLoS One 2015; 10: e0120154.

43.

Jennings

Mallios

Mushtaq

Proximal radial artery arteriovenous fistula for hemodialysis vascular access. J Vasc Surg 2018; 67: 244–253.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.48 MB

0.18 MB